VRK1 promotes DNA-induced type I interferon production
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09414-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Zhechen Fan und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Interferon Type I, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
BACKGROUND: Type I interferons (IFNs) are an essential class of cytokines with antitumor, antiviral and immunoregulatory effects. However, over-productive the type I IFNs are tightly associated with autoimmune disorders. Thus, the induction of type I interferons is precisely regulated to maintain immune hemostasis. This study aimed to identify a novel regulator of type I interferon signaling. METHODS AND RESULTS: Primary BMDMs, isolated from mice, and human cell lines (HEK293 cells, Hela cells) and murine cell line (MEF cells) were cultured to generate in vitro models. After knockdown VRK1, real-time PCR and dual-luciferase reporter assay were performed to determine the expression level of the type I IFNs and ISGs following HTDNA and Poly (dA:dT) stimulation. Additionally, cells were treated with the VRK1 inhibitor, and the impact of VRK1 inhibition was detected. Upon HTDNA and Poly (dA:dT) stimulation, knockdown of VRK1 attenuated the induction of the type I IFNs and ISGs. Consistently, VRK-IN-1, a potent and selective VRK1 inhibitor, significantly suppressed the induction of the type I IFNs and ISGs in human and murine cell lines. Further, VRK-IN-1 inhibited induction of the type I IFNs in mouse primary BMDMs. Intriguingly, VRK1 potentiated the cGAS-STING- IFN-I axis response at STING level. CONCLUSIONS: Our study reveals a novel function of VRK1 in regulating the production of type I IFNs. VRK-IN-1 might be a potential lead compound for suppressing aberrant type I IFNs in autoimmune disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
- State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. chenghao@cpu.edu.cn.
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China. mingypan@cityu.edu.hk.
Förderung
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Fan, Z., Wang, X., Cheng, H., & Pan, M. (2024). VRK1 promotes DNA-induced type I interferon production. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09414-8
Vancouver
Fan Z, Wang X, Cheng H, Pan M. VRK1 promotes DNA-induced type I interferon production. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09414-8
BibTeX
@article{Fan2024,
author = {Fan, Zhechen and Wang, Xiong and Cheng, Hao and Pan, Mingyu},
title = {VRK1 promotes DNA-induced type I interferon production},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09414-8}
}
EUVIMED